anatase titanium dioxide tio2 a100 for universal use supplier
Micronized TiO2 factories employ sophisticated processes that ensure a consistent product with precise particle size distribution. The production process begins with raw ore extraction, followed by beneficiation to remove impurities. The refined ore then goes through a chemical process that converts it into titanium dioxide. This conversion typically involves the sulfate or chloride process, where the ore reacts with sulfuric acid or chlorine gas, respectively.
Overall, titanium dioxide plays a vital role in both industrial applications and environmental protection. With China leading the way in the production of high-purity titanium dioxide, the country is well-positioned to meet the growing demand for this essential mineral. By continuing to invest in research and development, China can further enhance its capabilities in titanium dioxide production and contribute to the advancement of global technological innovation.
* Availability The supplier should have a reliable supply chain and be able to meet your demand for titanium dioxide.
On November 23, 2022, the General Court of the European Union reversed the conclusion that titanium dioxide was carcinogenic and released a statement (1,2):
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”
“First, the Commission made a manifest error in its assessment of the reliability and acceptability of the study on which the classification was based and, second, it infringed the criterion according to which that classification can relate only to a substance that has the intrinsic property to cause cancer.”
As part of our mission at CRIS we base our safety assessments on the currently available scientific evidence and consider many variables (e.g., study quality, journal of publication, etc.), even if it goes against previous conclusions. Evidence-informed decisions making is critical to ensure that the laws and regulations put into place are for the benefit of the population.
The EU General Court maintains that the scientific evidence presented wasn’t the complete picture for the ingredient, “in the present case, the requirement to base the classification of a carcinogenic substance on reliable and acceptable studies was not satisfied.”